Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

SC-55494 effective in combination with rhG-CSF

June 14, 1996

CCK-A agonists revealed by Glaxo Wellcome

June 14, 1996

Warner-Lambert seeks approval for atorvastatin

June 14, 1996

Monsanto reveals benzothiazepines with novel activity

June 14, 1996

ACAT inhibitors from Sankyo

June 14, 1996

Hyperlipidemia treatment from Takeda

June 14, 1996

Ligand/Wyeth-Ayerst collaboration extended

June 14, 1996

Phase I trial to begin for aerosolized form of osteoporosis drug

June 14, 1996

Sanofi Winthrop launches tiludronic acid

June 14, 1996

La Jolla Cancer Research Foundation claims mammalian trophinin

June 7, 1996

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...